Navigation Links
Alexza Initiates AZ-104 (Staccato(R) Loxapine) Phase 2b Clinical Trial in Patients With Migraine Headaches
Date:1/20/2009

administration, but with greater ease, patient comfort and convenience.

Alexza has five product candidates in clinical development. Alexza's lead program is AZ-004 (Staccato loxapine) that is being developed for the acute treatment of agitation in schizophrenic or bipolar disorder patients. Alexza has completed and announced positive initial results from both of its AZ-004 Phase 3 clinical trials, and is projecting a New Drug Application submission in early 2010. The Company has completed an end-of-Phase 2 meeting with the FDA for AZ-001 (Staccato prochlorperazine), and it has advanced AZ-104 (Staccato loxapine) into Phase 2b testing, both product candidates being developed for the acute treatment of migraine headache. Product candidates that have completed Phase 1 testing are AZ-003 (Staccato fentanyl) for the treatment of breakthrough pain, which is partnered with Endo Pharmaceuticals in North America, and AZ-007 (Staccato zaleplon) for the treatment of insomnia. More information, including this and past press releases from Alexza, is available online at http://www.alexza.com.

Safe Harbor Statement

This press release includes forward-looking statements regarding the development, therapeutic potential, efficacy and safety of AZ-104. Any statement describing a product candidate or Alexza's goals, expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of developing and commercializing drugs. The Company's forward-looking statements also involve assumptions that, if they prove incorrect, would cause its results to differ materially from those expressed or implied by such forward-looking statements. These and other risks conc
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... 16 Wound Management Technologies, Inc. ... provider of specialty medical products, announced today ... moving toward productization of its patented orthopedic ... anticipates products to be introduced in Q3 ... be a multi-billion dollar international market. ,, ...
(Date:12/16/2009)... 16 DATATRAK International, Inc. (OTCQX: ... on global eClinical solutions for the clinical ... its version 9.0 eClinical Software. This ... product and service delivery and introduces two ... offering: the DATATRAK Learning Center(TM) and the ...
(Date:12/16/2009)... Ill., Dec. 16 Hospira, Inc. (NYSE: ... medication delivery company, today announced that it will host ... 2009 results and projections for 2010 on Thursday, Feb. ... company will release its fourth-quarter and full-year 2009 results ... and the conference call. ,, A live webcast of ...
Breaking Medicine Technology:Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics 2Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics 3DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 3DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 4In Letter to President TPC Highlights Foundation Grants in Health 56686 1In Letter to President TPC Highlights Foundation Grants in Health 56686 2In Letter to President TPC Highlights Foundation Grants in Health 56686 3FDA Panel Backs Giving HPV Vaccine Gardasil to Young Males 56683 1FDA Panel Backs Giving HPV Vaccine Gardasil to Young Males 56683 2FDA Panel Backs Giving HPV Vaccine Gardasil to Young Males 56683 3FDA Panel Backs Giving HPV Vaccine Gardasil to Young Males 56683 4Childrens Hospital receives federal contract to study antibiotic use in children with UTIs 56680 1
(Date:12/16/2009)... been found, , , WEDNESDAY, Dec. 16 (HealthDay News) -- ... food poisoning and the stomach pain and diarrhea that ... urinary tract infections. , Researchers have found the same ... restaurants and in women with the infections. , ... to the women through the food they ate, although ...
(Date:12/16/2009)... Reduction Therapy or NSRTSM is found very effective in the ... allergies, asthma, migraines, chronic fatigue and a wide array of ... are using this holistic therapy including over 50 branded BioVeda ... ... Minneapolis, MN (Vocus) December 14, 2009 -- BioVeda Health and ...
(Date:12/16/2009)... factor for use, expert says, , , WEDNESDAY, Dec. 16 ... much less likely to die when they receive an ... study included 4,685 people, ages 65 to 85, who ... ventricular fraction (a measure of the heart,s pumping ability) ... period, those who were treated with standard medication and ...
(Date:12/16/2009)... low, government report shows, , , WEDNESDAY, Dec. 16 (HealthDay ... has reached almost 78 years, a record high, federal ... women can expect to live to 80.4 years on ... report from the U.S. Centers for Disease Control and ... to live longer than their parents, life expectancy in ...
(Date:12/16/2009)... OrthoAccel Technologies, Inc., developers of the AcceleDent ... enhance orthodontics, announced Alison Davies as its new ... Davies has spent the last fourteen years of ... recently for nine years as a senior manager ... Invisalign . ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20091029/DA01250LOGO ...
Breaking Medicine News(10 mins):Health News:Foodborne E. Coli Suspected in Urinary Tract Infections 2Health News:Foodborne E. Coli Suspected in Urinary Tract Infections 3Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 2Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 3Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 4Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 5Health News:Implanted Defibrillator Might Extend Life 2Health News: Life Expectancy in U.S. Hits New High 2Health News: Life Expectancy in U.S. Hits New High 3Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 2Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 3Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 4
... Bull - expert in open,flexible and secure information ... players in the IT industry - announces it ... its Medicaid solutions,business, mainly dedicated to Public Health ... Ingenix, a leading health information, technology,and consulting services ...
... helping fight against childhood obesity, researcher notes , , MONDAY, ... have vending machines where snacks and sugared drinks are ... that there are vending machines in most middle schools, ... healthiest choices," said study author Amy Virus, a registered ...
... Oct. 6 HealthSouth,Corporation (NYSE: HLS ) today announced the details of ... 2008 at 8:30 a.m. EST at the Grand Hyatt New York, located at,109 ... 8:00 a.m. Continental Breakfast 8:30 a.m. Jay Grinney, ... -- HealthSouth Overview and Industry Trends ...
... members can take,anonymous online, telephone or in-person self-assessments, ... Service members and their families that are unique and,difficult. ... matters get,worse and one problem can trigger other more ... things out to see what is really happening., ...
... of California, San Diego School of Medicine suggests that use ... chemical normally found in the skin, and may help prevent ... the most common form of eczema. , The study ... chief of the Division of Dermatology at the UCSD School ...
... special supplement of the Oct. 15,journal Cancer for ... countries to implement breast cancer programs to detect ... "Guidelines for International Breast Health and Cancer ... Initiative (BHGI),outlines a tiered system of resource allocation ...
Other Medicine News:Health News:Bull Continues Repositioning and Announces the Acquisition of its Medicaid Solutions Business in the United States by Ingenix 2Health News:Bull Continues Repositioning and Announces the Acquisition of its Medicaid Solutions Business in the United States by Ingenix 3Health News:Vending Machines Found in Most Middle Schools 2Health News:HealthSouth to Hold Investor Meeting November 10, 2008 2Health News:Many Military Installations Worldwide Participate in National Depression Screening Day 2Health News:Many Military Installations Worldwide Participate in National Depression Screening Day 3Health News:Oral vitamin D may help prevent some skin infections 2Health News:International Implementation of Breast Health Guidelines for Developing Countries Published by Cancer 2Health News:International Implementation of Breast Health Guidelines for Developing Countries Published by Cancer 3
Delicate membrane spatula with serrated rake tip. 20 gauge shaft with balanced titanium handle. Dark finish for reduced glare....
Wedge-shaped chopper designed to allow nucleus chopping in three directions, tip length 1.25 mm. Rounded tip highly polished to protect the posterior capsule. 0.5 mm spatula end is used to manipulate...
11 mm angled tip with gently curved blade. Flat serrated handle with polished finish....
0.5 mm x 10 mm angled blade with blunt tip. Flat smooth handle with polished finish....
Medicine Products: